Alerts will be sent to your verified email
Verify Email
MEDICO
|
Medico Remedies
|
Kimia Biosciences
|
Trident Lifeline
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.79 % | -352.38 % | 35.94 % |
|
5yr average Equity Multiplier
|
2.18 | 65.1 | 1.91 |
|
5yr Average Asset Turnover Ratio
|
1.48 | 1.17 | 0.9 |
|
5yr Avg Net Profit Margin
|
3.76 % | -2.03 % | 17.11 % |
|
Price to Book
|
5.59 | 0.0 | 5.59 |
|
P/E
|
34.54 | 39.76 | 27.41 |
|
5yr Avg Cash Conversion Cycle
|
34.15 Days | 28.76 Days | 94.4 Days |
|
Inventory Days
|
52.67 Days | 94.07 Days | 68.55 Days |
|
Days Receivable
|
107.96 Days | 101.18 Days | 104.41 Days |
|
Days Payable
|
136.18 Days | 144.79 Days | 126.58 Days |
|
5yr Average Interest Coverage Ratio
|
9.64 | 0.28 | 17.94 |
|
5yr Avg ROCE
|
17.25 % | -0.98 % | 29.15 % |
|
5yr Avg Operating Profit Margin
|
5.84 % | 1.32 % | 16.89 % |
|
5 yr average Debt to Equity
|
0.3 | 29.7 | 0.34 |
|
5yr CAGR Net Profit
|
38.44 % | n/a | 9.93 % |
|
5yr Average Return on Assets
|
5.66 % | -2.12 % | 15.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.79 % | 74.94 % | 63.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 3.46 % |
|
Change in Promoter Holding (3 Yrs)
|
-9.55 % | 0.0 | -6.53 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Medico Remedies
|
Kimia Biosciences
|
Trident Lifeline
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|